174 related articles for article (PubMed ID: 23919188)
1. Serum leptin level in women with polycystic ovary syndrome: correlation with adiposity, insulin, and circulating testosterone.
Chakrabarti J
Ann Med Health Sci Res; 2013 Apr; 3(2):191-6. PubMed ID: 23919188
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
[TBL] [Abstract][Full Text] [Related]
3. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.
Chapman IM; Wittert GA; Norman RJ
Clin Endocrinol (Oxf); 1997 Feb; 46(2):175-81. PubMed ID: 9135699
[TBL] [Abstract][Full Text] [Related]
4. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
de Medeiros SF; Rodgers RJ; Norman RJ
Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
6. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
7. Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain.
Golbahar J; Al-Ayadhi M; Das NM; Gumaa K
Int J Womens Health; 2012; 4():201-6. PubMed ID: 22654525
[TBL] [Abstract][Full Text] [Related]
8. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.
Vicennati V; Gambineri A; Calzoni F; Casimirri F; Macor C; Vettor R; Pasquali R
Metabolism; 1998 Aug; 47(8):988-92. PubMed ID: 9711997
[TBL] [Abstract][Full Text] [Related]
9. Serum leptin level-insulin resistance-based correlation in polycystic ovary syndrome obese and non-obese sufferer female.
Sharif YH
J Popul Ther Clin Pharmacol; 2022; 29(2):e11-e19. PubMed ID: 35848192
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome.
El Orabi H; Ghalia AA; Khalifa A; Mahfouz H; El Shalkani A; Shoieb N
Clin Biochem; 1999 Feb; 32(1):71-5. PubMed ID: 10074895
[TBL] [Abstract][Full Text] [Related]
11. Influence of adiposity on leptin, LH and androgen levels in lean, overweight and obese PCOS patients.
LaZovic G; Radivojevic U; Milicevic S; Spremovic S
Int J Fertil Womens Med; 2007; 52(2-3):82-8. PubMed ID: 18320865
[TBL] [Abstract][Full Text] [Related]
12. Association of Serum Leptin with Anthropometric Indices of Obesity, Blood Lipids, Steroidal Hormones, and Insulin Resistance in Polycystic Ovarian Syndrome.
Kumawat M; Choudhary P; Aggarwal S
J Hum Reprod Sci; 2021; 14(3):228-233. PubMed ID: 34759611
[TBL] [Abstract][Full Text] [Related]
13. Serum leptin and ghrelin levels in women with polycystic ovary syndrome: correlation with anthropometric, metabolic, and endocrine parameters.
Houjeghani S; Pourghassem Gargari B; Farzadi L
Int J Fertil Steril; 2012 Jul; 6(2):117-26. PubMed ID: 25493169
[TBL] [Abstract][Full Text] [Related]
14. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements.
Spritzer PM; Poy M; Wiltgen D; Mylius LS; Capp E
Hum Reprod; 2001 Jul; 16(7):1340-6. PubMed ID: 11425810
[TBL] [Abstract][Full Text] [Related]
15. Are circulating leptin and luteinizing hormone synchronized in patients with polycystic ovary syndrome?
Sir-Petermann T; Piwonka V; Pérez F; Maliqueo M; Recabarren SE; Wildt L
Hum Reprod; 1999 Jun; 14(6):1435-9. PubMed ID: 10357954
[TBL] [Abstract][Full Text] [Related]
16. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
17. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.
Fusco A; Bianchi A; Mancini A; Milardi D; Giampietro A; Cimino V; Porcelli T; Romualdi D; Guido M; Lanzone A; Pontecorvi A; De Marinis L
J Endocrinol Invest; 2007 Dec; 30(11):948-56. PubMed ID: 18250617
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
19. Leptin concentrations in the polycystic ovary syndrome.
Mantzoros CS; Dunaif A; Flier JS
J Clin Endocrinol Metab; 1997 Jun; 82(6):1687-91. PubMed ID: 9177364
[TBL] [Abstract][Full Text] [Related]
20. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
Arroyo A; Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
